1. Home
  2. CIM vs ABCL Comparison

CIM vs ABCL Comparison

Compare CIM & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chimera Investment Corporation

CIM

Chimera Investment Corporation

HOLD

Current Price

$12.48

Market Cap

1.0B

Sector

Real Estate

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.89

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIM
ABCL
Founded
2007
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
CIM
ABCL
Price
$12.48
$3.89
Analyst Decision
Buy
Buy
Analyst Count
3
5
Target Price
$15.25
$7.75
AVG Volume (30 Days)
823.7K
3.2M
Earning Date
02-11-2026
11-06-2025
Dividend Yield
11.67%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$191,573,000.00
$35,325,000.00
Revenue This Year
$11.44
$25.45
Revenue Next Year
$21.50
$10.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.17
52 Week Low
$9.85
$1.89
52 Week High
$15.37
$6.52

Technical Indicators

Market Signals
Indicator
CIM
ABCL
Relative Strength Index (RSI) 44.43 57.83
Support Level $12.30 $3.34
Resistance Level $12.81 $3.82
Average True Range (ATR) 0.25 0.20
MACD -0.04 0.04
Stochastic Oscillator 26.03 95.75

Price Performance

Historical Comparison
CIM
ABCL

About CIM Chimera Investment Corporation

Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: